Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dipyridamole increases red cell deformability.

S O Sowemimo-Coker, I B Kovacs, H Pickles

    British Journal of Clinical Pharmacology
    |October 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute toxicity of three alkylbenzene sulfonates in six freshwater aquatic species.

    Ecotoxicology and environmental safety·2025
    Same author

    Factors affecting the species of Campylobacter colonizing chickens reared for meat.

    Journal of applied microbiology·2020
    Same author

    Involvement of homocysteine, homocysteine thiolactone, and paraoxonase type 1 (PON-1) in the etiology of defective human sperm function.

    Andrology·2016
    Same author

    Preliminary assessment of RX 72601, a new anticholinesterase in man: reversal of competitive neuromuscular blockade.

    British journal of clinical pharmacology·2012
    Same author

    Pandemic flu.

    British dental journal·2006
    Same author

    Enhanced spontaneous thrombolysis: a new therapeutic challenge.

    Journal of thrombosis and thrombolysis·2006

    Dipyridamole significantly improves red blood cell filterability in healthy volunteers, enhancing cell deformability. This effect was observed ex vivo, suggesting a potential therapeutic benefit by improving blood flow.

    Area of Science:

    • Pharmacology
    • Hematology
    • Biomedical Engineering

    Background:

    • Red blood cell (RBC) deformability is crucial for microcirculation.
    • Impaired RBC filterability is associated with various vascular diseases.
    • Dipyridamole is a known vasodilator and antiplatelet agent.

    Purpose of the Study:

    • To investigate the effects of dipyridamole on RBC filterability.
    • To determine if dipyridamole enhances RBC deformability ex vivo and in vitro.
    • To explore the potential mechanism of dipyridamole's action on RBCs.

    Main Methods:

    • A randomized, double-blind, placebo-controlled trial in healthy volunteers.
    • Ex vivo assessment of RBC filterability after oral dipyridamole administration.
    • In vitro incubation of RBCs with dipyridamole at different concentrations.

    Related Experiment Videos

  • Evaluation of RBC filterability after cold storage with and without dipyridamole.

    • Main Results:

    • Oral dipyridamole significantly increased RBC filterability compared to placebo (P < 0.05).
    • In vitro incubation showed no immediate effect on fresh RBC filterability.
    • Dipyridamole partially prevented the decrease in RBC filterability after 24-hour storage at 4°C (P < 0.05).

    Conclusions:

    • Dipyridamole enhances RBC deformability, particularly under conditions mimicking storage.
    • The drug appears to influence RBC membrane properties.
    • These findings suggest dipyridamole may improve hemorheology and contribute to its therapeutic efficacy.